Navigation Links
Vivant Skin Care Introduces 8% Mandelic Acid 3-in-1 Serum for Those New to Advanced Skin Care
Date:7/25/2012

MIAMI LAKES, Fla., July 25, 2012 /PRNewswire-iReach/ -- Vivant Skin Care recently added 8% Mandelic Acid 3-in-1 Serum to its already expansive range of skin care products. The multi-purpose product is now available through skin care wholesalers throughout the upper 48, Hawaii and internationally, plus on the company's retail website.

(Photo:  http://photos.prnewswire.com/prnh/20120725/CG44976)

"This new release represents the latest Vivant initiative to introduce user-friendly, multi-use products geared to those looking for an introduction to clinical skin care products," says CEO Kelly Kendrick. "We feel strongly about making Vivant products accessible to a broad range of users and have put an extensive amount of research and testing time into the process."

8% Mandelic Acid 3-in-1 Serum is alcohol-free and has a low percentage acid content that is perfect for sensitive and dry skin types. Dramatically improving the appearance of acne, hyperpigmentation and fighting the visible effects of aging, it is ideal for beginners, sensitive skin types and darker skin tones. The gentle formula targets adult acne, age spots, discoloration and helps diminish the appearance of wrinkles. Key ingredients also include lactic acid and niacinamide (vitamin B3).

The one (1) ounce bottle retails for $62. For more information and to purchase the 8% Mandelic Acid 3-in-1 Serum, call 855.4.VIVANT (855.484.8268) to find an authorized provider near you or navigate to http://vivantskincare.com/8-mandelic-acid-3-in-1-serum.

ABOUT VIVANT SKIN CARE

Vivant Skin Care is a family-owned company with more than 40 years' experience in the research, formulation and development of high-quality, corrective and preventative skin care products.  Now located at 5753 NW 158 Street in Miami Lakes, FL, the company recently began selling its line to the direct-to-retail market after having been an exclusively wholesale business since 1990. Prior to this shift, their products were successfully sold through doctors' offices and medical spas. In addition to growing the wholesale end of its business model, Vivant is now actively pursuing additional retail and international opportunities.

The Vivant research and development team, led by author, noted speaker and Lead Formulating Consultant Dr. James E. Fulton, MD, Ph.D., the co-developer of Retin A®, has created a powerful and cost-effective line of skin care products. Vivant also supports their skin care professional distributors with ongoing education, seminars, suggested protocols and product manuals.

Vivant Skin Care's products successfully treat resistant skin conditions found in ethnic skin types such as hyperpigmentation (melasma) and acne, giving them a natural acceptability rate in the Latin American and Caribbean marketplaces. An estimated 45-50 million women worldwide live with melasma, a condition that presents itself as unattractive brown patches or uneven skin color.  The Vivant Skin Care line provides a non-surgical alternative to achieving even and clear skin.

For more information and to shop online, visit www.VivantSkinCare.com, like them on www.facebook.com/VivantSkin, follow them on www.twitter.com/VivantSkinCare and www.pinterest.com/VivantSkinCare and view their videos at www.youtube.com/VivantSkin. Call them toll-free at 855.4.VIVANT (855.484.8268).

Media Contact: Michael Mut, Vivant Skin Care, 786.426.2277, michael@vivantskincare.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Vivant Skin Care
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Milton Owens, Well Known Bariatric Surgeon, Introduces Innovative "Inverted Corner Gastric Sleeve technique," An advanced technique that makes weight loss surgery even safer
2. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
3. Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States
4. PharmaNet/i3 Introduces PharmaNet/i3 Strategic Resourcing
5. PeriGen, Inc. Introduces New, Advanced Perinatal System at National Perinatal Nursing Convention
6. HealthONE® Introduces the Colorado Center for Robotic Surgery(SM)
7. ConvaTec Introduces Enhanced Flexi-Seal® SIGNAL® FMS
8. IDEV Technologies Introduces SurePath™ Guidewires
9. Velos, Inc. Introduces Mobile App for Oncology Adverse Events and Graft-Versus-Host Disease at 2012 ASCO Annual Meeting
10. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
11. Richard Wolf Medical Instruments introduces groundbreaking 5514 Endocam Performance HD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
(Date:9/7/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ), ... cell and tissue hypothermic storage and cryopreservation ... President and CEO, will be presenting at two investment conferences ... 19 th Annual Global Investment Conference on Tuesday, September ... The conference is being held at the New York Palace ...
Breaking Medicine Technology:
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... Illustrate, Maintain® methodology and industry-leading compliance software, The Guard®, has helped another long-time ... Rights (OCR) HIPAA audit and properly satisfy the law. , Thanks to the ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... and social campaign, “Humans With Vaginas.” The goal is to ignite conversation via ... non-toxic personal care products. The brand has declared September “Humans with Vaginas” month, ...
(Date:9/20/2017)... ... 20, 2017 , ... Medicare doesn’t have the authority to ... for their prescription drugs, according to a new comparison of drug plans by ... behalf, there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Trials I Face to Receive ... he emotionally pens his aspirations and goals to better one’s life through God. “The ... Green, while searching in all the wrong places, found a love for writing. Green ...
(Date:9/20/2017)... ... September 20, 2017 , ... Houston, Texas, investment firm CORDA Investment ... 8, and Monday, September 11, off work and rolled up their sleeves to help ... to local homes to start the process of rebuilding. , CORDA founder Bonner C. ...
Breaking Medicine News(10 mins):